Aridis Pharmaceuticals, Inc. Business Finance Contracts & Agreements
26 Contracts & Agreements
- Note Agreements (4 contracts)
- Purchase Agreements (9)
- Security Agreements (2)
- Stock Agreements (1)
- Underwriting Agreements (1)
- Warrant Agreements (9)
- Form of Securities Purchase Agreement (Filed With SEC on June 27, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on July 21, 2023)
- Form of Warrant (Filed With SEC on July 21, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 27, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 27, 2023)
- Form of Warrant (Filed With SEC on June 27, 2023)
- Security Agreement dated as of April 26, 2023 (Filed With SEC on May 1, 2023)
- Note Purchase Agreement dated as of April 26, 2023 (Filed With SEC on May 1, 2023)
- Form of Secured Promissory Note (Filed With SEC on May 1, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 15, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on December 12, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on October 5, 2022)
- Form of Warrant (Filed With SEC on October 5, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on October 5, 2022)
- Security Agreement dated as of November 23, 2021 (Filed With SEC on November 30, 2021)
- Note Purchase Agreement dated as of November 23, 2021 (Filed With SEC on November 30, 2021)
- Form of Secured Promissory Note (Filed With SEC on November 30, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on August 4, 2021)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on August 4, 2021)
- Form of Common Stock Purchase Warrant (Filed With SEC on August 4, 2021)
- Form of Securities Purchase Agreement, dated March 15, 2021, by and between Aridis Pharmaceuticals, Inc. and the Purchasers (Filed With SEC on March 15, 2021)
- Form of Series B Warrant (Filed With SEC on October 14, 2020)
- Form of Series A Warrant (Filed With SEC on October 14, 2020)
- Form of Securities Purchase Agreement, dated October 13, 2020, by and between Aridis Pharmaceuticals, Inc. and the Purchasers (Filed With SEC on October 14, 2020)
- Stock Subscription Agreement, dated July 19, 2019 (Filed With SEC on July 30, 2019)
- Aridis Pharmaceuticals, Inc. [] Shares Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on August 6, 2018)
